LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.17783
39.41 27.76 1631 3105 0.5252 0.8194
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
39.41 27.76 44 3105 0.0142 0.0700
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
39.41 27.76 1721 3105 0.5542 0.8338
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
41.11 27.76 49 3331 0.0147 0.0858
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
41.11 27.76 1688 3331 0.5067 0.8125
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
41.11 27.76 54 3331 0.0162 0.1011
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
41.11 27.76 1852 3331 0.5559 0.8370
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
42.81 27.76 40 3596 0.0111 0.0534
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
42.81 27.76 1764 3596 0.4905 0.8070
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
42.81 27.76 72 3596 0.0200 0.1455
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
42.81 27.76 1945 3596 0.5408 0.8323
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
44.52 27.76 48 3884 0.0124 0.0799
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
44.52 27.76 1851 3884 0.4765 0.8025
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
44.52 27.76 76 3884 0.0196 0.1518
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
44.52 27.76 2068 3884 0.5324 0.8307
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
46.22 27.76 68 4125 0.0165 0.1322
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
46.22 27.76 1935 4125 0.4691 0.8008
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
46.22 27.76 65 4125 0.0158 0.1252
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
46.22 27.76 2180 4125 0.5285 0.8308
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
47.93 27.76 58 4421 0.0131 0.1060
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
47.93 27.76 2052 4421 0.4641 0.8008
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
47.93 27.76 67 4421 0.0152 0.1280
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
47.93 27.76 2246 4421 0.5080 0.8231
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
49.63 27.76 54 4818 0.0112 0.0936
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
49.63 27.76 2066 4818 0.4288 0.7848
MN20160318_Q01
E22